FMVQX | VMVAX | FMVQX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 13 years | - |
Gain YTD | 10.717 | 11.523 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 443M | 32.8B | 1% |
Annual Yield % from dividends | 1.23 | 2.14 | 57% |
Returns for 1 year | 11.58 | 11.15 | 104% |
Returns for 3 years | 11.21 | 11.18 | 100% |
Returns for 5 years | 41.83 | 36.17 | 116% |
Returns for 10 years | N/A | 83.84 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSPRX | 22.26 | 0.14 | +0.63% |
Morgan Stanley Inst Advantage C | |||
MDOEX | 10.58 | 0.05 | +0.47% |
Morgan Stanley Developing Opportunity I | |||
FTMCX | 24.61 | N/A | N/A |
First Trust Multi-Strategy Cl C | |||
VMVLX | 252.99 | -1.38 | -0.54% |
Vanguard Mega Cap Value Index Instl | |||
KTCSX | 42.27 | -0.31 | -0.73% |
DWS Science and Technology S |